miR-139-3p/Kinesin family member 18B axis suppresses malignant progression of gastric cancer

References

• Van Cutsem E, Sagaert X, Topal B, et al. Gastric cancer. Lancet. 2016;388(10060):2654–2664.
   PubMed Web of Science ®Google Scholar
• Ajani JA, Lee J, Sano T, et al. Gastric adenocarcinoma. Nat Rev Dis Primers. 2017;3(1):17036.
   PubMedGoogle Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Song Z, Wu Y, Yang J, et al. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017;39(7):1010428317714626.
   Google Scholar
• Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700–713.
   PubMed Web of Science ®Google Scholar
• Lazăr DC, Avram MF, Romoșan I, et al. Prognostic significance of tumor immune microenvironment and immunotherapy: novel insights and future perspectives in gastric cancer. World J Gastroenterol. 2018;24(32):3583–3616.
   PubMed Web of Science ®Google Scholar
• Yang W, Raufi A, Klempner SJ. Targeted therapy for gastric cancer: molecular pathways and ongoing investigations. Biochim Biophys Acta. 2014;1846(1):232–237.
   PubMed Web of Science ®Google Scholar
• Li J, Ye D, Shen P, et al. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway. J Exp Clin Cancer Res. 2020;39(1):212.
   PubMed Web of Science ®Google Scholar
• Xu Z, Li Z, Wang W, et al. MIR-1265 regulates cellular proliferation and apoptosis by targeting calcium binding protein 39 in gastric cancer and, thereby, impairing oncogenic autophagy. Cancer Lett. 2019;449:226–236.
   PubMed Web of Science ®Google Scholar
• Yang XZ, Cheng TT, He QJ, et al. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway. Mol Cancer. 2018;17(1):126.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang L, Guo X, et al. Self-assembled RNA nanocarrier-mediated chemotherapy combined with molecular targeting in the treatment of esophageal squamous cell carcinoma. J Nanobiotechnology. 2021;19(1):388.
   PubMed Web of Science ®Google Scholar
• Cao D, Cao X, Jiang Y, et al. Circulating exosomal microRNAs as diagnostic and prognostic biomarkers in patients with diffuse large B-cell lymphoma. Hematol Oncol. 2021. DOI:10.1002/hon.2956.
   Web of Science ®Google Scholar
• Stavast CJ, van Zuijen I, Karkoulia E, et al. The tumor suppressor MIR139 is silenced by POLR2M to promote AML oncogenesis. Leukemia. 2021. DOI:10.1038/s41375-021-01461-5.
   Web of Science ®Google Scholar
• Zhu X, Jiang S, Wu Z, et al. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis. Bioengineered. 2021;12(1):578–588.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang J, Liu M, et al. Clinical values and potential pathways of miR-183-5p in gastric cancer: a study based on integrational bioinformatics analysis. J Gastrointest Oncol. 2021;12(5):2123–2131.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zou L, Sun P. Relationship between miR-378c and YY1 expression in patients with gastric cancer and the clinicopathological features. Cell Mol Biol Lett. 2021;26(1):12.
   PubMed Web of Science ®Google Scholar
• Zou W, Wang Y, Song Q, et al. Ultrasound-targeted microbubble destruction mediated miR-492 inhibitor suppresses the tumorigenesis in non-small cell lung cancer. Ann Med. 2021;53(1):2246–2255.
   PubMed Web of Science ®Google Scholar
• Yang Y, Gao M, Li Y, et al. LncRNA CTBP1-AS2 facilitates gastric cancer progression via regulating the miR-139-3p/MMP11 axis. Onco Targets Ther. 2020;13:11537–11547.
   PubMedGoogle Scholar
• Jiang L, Zhang Y, Guo L, et al. Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway. BMC Cancer. 2021;21(1):1290.
   PubMed Web of Science ®Google Scholar
• Li Z, Cheng Y, Fu K, et al. Circ-PTPDC1 promotes the progression of gastric cancer through sponging Mir-139-3p by regulating ELK1 and functions as a prognostic biomarker. Int J Biol Sci. 2021;17(15):4285–4304.
   PubMed Web of Science ®Google Scholar
• Zhang W, Xu J, Wang K, et al. miR‑139‑3p suppresses the invasion and migration properties of breast cancer cells by targeting RAB1A. Oncol Rep. 2019;42(5):1699–1708.
   PubMed Web of Science ®Google Scholar
• Xue F, Li QR, Xu YH, et al. MicroRNA-139-3p inhibits the growth and metastasis of ovarian cancer by inhibiting ELAVL1. Onco Targets Ther. 2019;12:8935–8945.
   PubMed Web of Science ®Google Scholar
• Xia Z, Yang X, Wu S, et al. LncRNA TP73-AS1 down-regulates miR-139-3p to promote retinoblastoma cell proliferation. Biosci Rep. 2019;39(5). DOI:10.1042/BSR20190475.
   Google Scholar
• Wu Y, Wang A, Zhu B, et al. KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer. Onco Targets Ther. 2018;11:1707–1720.
   PubMed Web of Science ®Google Scholar
• Chen FT, Zhong FK. Kinesin family member 18A (KIF18A) contributes to the proliferation, migration, and invasion of lung adenocarcinoma cells in vitro and in vivo. Dis Markers. 2019;2019:6383685.
   PubMedGoogle Scholar
• Koma A, Asai S, Minemura C, et al. Impact of oncogenic targets by tumor-suppressive miR-139-5p and miR-139-3p regulation in head and neck squamous cell carcinoma. Int J Mol Sci. 2021;22(18):9947.
   PubMed Web of Science ®Google Scholar
• Yan S, Xu J, Liu B, et al. Long non-coding RNA BCAR4 aggravated proliferation and migration in esophageal squamous cell carcinoma by negatively regulating p53/p21 signaling pathway. Bioengineered. 2021;12(1):682–696.
   PubMed Web of Science ®Google Scholar
• Hong B, Lu R, Lou W, et al. KIF18b-dependent hypomethylation of PARPBP gene promoter enhances oxaliplatin resistance in colorectal cancer. Exp Cell Res. 2021;407(2):112827.
   PubMed Web of Science ®Google Scholar
• Qiu MJ, Wang QS, Li QT, et al. KIF18B is a prognostic biomarker and correlates with immune infiltrates in pan-cancer. Front Mol Biosci. 2021;8:559800.
   PubMed Web of Science ®Google Scholar
• Wu YP, Ke ZB, Zheng WC, et al. Kinesin family member 18B regulates the proliferation and invasion of human prostate cancer cells. Cell Death Dis. 2021;12(4):302.
   PubMed Web of Science ®Google Scholar